Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Giladi

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|February 17, 2018
Who will remain tremor dominant? The possible role of cognitive reserve in the time course of two common Parkinson's disease motor subtypesTalia Herman, S Shema-Shiratzky, L Arie, et al.
Israel Journal of Medical Sciences|November 1, 1994
Interventional neurology: botulinum toxin as a potent symptomatic treatment in neurologyN Giladi, J Meer, C Kidan, et al.
Clinical Neuropharmacology|December 17, 2004
Tetrabenazine treatment in movement disordersD Paleacu, N Giladi, O Moore, et al.
Journal of Neurology|September 8, 2017
Do cognition and other non-motor symptoms decline similarly among patients with Parkinson's disease motor subtypes? Findings from a 5-year prospective studyL Arie, Talia Herman, S Shema-Shiratzky, et al.
Israel Journal of Medical Sciences|February 1, 1997
The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy--a pilot studyN Zelnik, N Giladi, I Goikhman, et al.
Acta Neurologica Scandinavica|May 19, 2004
Subdivision of essential tremor patients according to physiologic characteristicsD Golan, N Giladi, R Thorne, et al.
Parkinsonism & Related Disorders|June 1, 2002
Quality of sexual life in Parkinson's diseaseO Moore, T Gurevich, A D Korczyn, et al.
Journal of Neurology|May 17, 2005
Falls in outpatients with Parkinson's disease: frequency, impact and identifying factorsY Balash, C Peretz, G Leibovich, et al.
American Journal of Medical Genetics. Part A|December 18, 2003
Different phenotypic expression in monozygotic twins with Huntington diseaseM H Anca, E Gazit, R Loewenthal, et al.
Physiological Measurement|November 19, 2011
An instrumented timed up and go: the added value of an accelerometer for identifying fall risk in idiopathic fallersA Weiss, T Herman, M Plotnik, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Journal of Neural Transmission (Vienna, Austria : 1996)|February 17, 2018
Who will remain tremor dominant? The possible role of cognitive reserve in the time course of two common Parkinson's disease motor subtypesTalia Herman, S Shema-Shiratzky, L Arie, et al.
Israel Journal of Medical Sciences|November 1, 1994
Interventional neurology: botulinum toxin as a potent symptomatic treatment in neurologyN Giladi, J Meer, C Kidan, et al.
Clinical Neuropharmacology|December 17, 2004
Tetrabenazine treatment in movement disordersD Paleacu, N Giladi, O Moore, et al.
Journal of Neurology|September 8, 2017
Do cognition and other non-motor symptoms decline similarly among patients with Parkinson's disease motor subtypes? Findings from a 5-year prospective studyL Arie, Talia Herman, S Shema-Shiratzky, et al.
Israel Journal of Medical Sciences|February 1, 1997
The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy--a pilot studyN Zelnik, N Giladi, I Goikhman, et al.
Acta Neurologica Scandinavica|May 19, 2004
Subdivision of essential tremor patients according to physiologic characteristicsD Golan, N Giladi, R Thorne, et al.
Parkinsonism & Related Disorders|June 1, 2002
Quality of sexual life in Parkinson's diseaseO Moore, T Gurevich, A D Korczyn, et al.
Journal of Neurology|May 17, 2005
Falls in outpatients with Parkinson's disease: frequency, impact and identifying factorsY Balash, C Peretz, G Leibovich, et al.
American Journal of Medical Genetics. Part A|December 18, 2003
Different phenotypic expression in monozygotic twins with Huntington diseaseM H Anca, E Gazit, R Loewenthal, et al.
Physiological Measurement|November 19, 2011
An instrumented timed up and go: the added value of an accelerometer for identifying fall risk in idiopathic fallersA Weiss, T Herman, M Plotnik, et al.
Pageof 12